Marwa Sharaky

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Designing Telomerase Inhibitors for Cancer Therapy: Mechanistic Insights, Medicinal Chemistry Strategies, Challenges, and Future Directions.

|Apr 04, 2026
Targeting the Menin-KMT2A Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader Inhibitors.

Ahmed A Al-Karmalawy, Mohamed E Eissa, Tarek A Yousef

|Feb 19, 2026
Investigating the Telomerase Downregulatory Potential of Steroidal Drugs Following Pharmacophore-Based Rational; Computational and In Vitro Assessments.

Ahmed A Al-Karmalawy, Aya Yaseen Mahmood Alabdali, Tarek A Yousef

|Nov 17, 2025
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer Treatment.

Saad Shaaban, Ayman Abo Elmaaty, Aya Yaseen Mahmood Alabdali

|Oct 07, 2025
Multi-Target Rational Design and Synthesis of Some 2-Quinolinone Antitumor Candidates Downregulating the Expression of EGFR, VEGFR-2, and Telomerase With Apoptotic Potential.

Eman A E El-Helw, Mai H A Mousa, Eman A Ghareeb

|Sep 09, 2025
Rutin Alleviates Breast Cancer Resistance to Tamoxifen By Downregulating ABC Transporters, Inducing ROS Generation and Resetting Redox Status.

Heba Effat, Aliaa M Radwan, Marwa Sharaky

Pageof 2

Frequent Collaborators

6 joint publications

Ahmed A Al-Karmalawy

6 joint publications

Arwa Omar Al Khatib

5 joint publications

Tarek A Yousef

3 joint publications

Ayman Abo Elmaaty